跳至主要内容
临床试验/ACTRN12618000563268
ACTRN12618000563268已完成1 期

A multiple dose, randomized, blinded, bioequivalence study of a test formulation of 1,1-Dimethyl-2-Phenylethylamine 40 mg capsule in a 2 way crossover comparison against the innovator 1,1-Dimethyl-2-Phenylethylamine 40 mg capsule conducted under fasting and steady state conditions in healthy male and female volunteers.

Zenith Technology Corporation Limited0 个研究点目标入组 24 人开始时间: 2018年4月13日最近更新:

试验速览

阶段
1 期
状态
已完成
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 55 Years(—)
性别
All

入选标准

  • 未提供

排除标准

  • 未提供

研究者

相似试验

已完成
1 期
Comparative assessment of the absorption of a generic formulation of melatonin prolonged release tablet against the innovator melatonin prolonged release tablet conducted under fasting conditions and at steady state in healthy male and female volunteersBioequivalence study conducted in healthy volunteers comparing two formulations of melatonin with no health condition or problem studied.Although this study is being conducted in healthy volunteers who are not being treated for the condition to which the medicine is used, melatonin is a naturally occurring hormone produced by the pineal gland and is indicated as monotherapy for the short term treatment of primary insomnia characterised by poor quality of sleep in patients who are aged 55 or over.Bioequivalence study conducted in healthy volunteers comparing two formulations of melatonin with no health condition or problem studied.Although this study is being conducted in healthy volunteers who are not being treated for the condition to which the medicine is used, melatonin is a naturally occurring hormone produced by the pineal gland and is indicated as monotherapy for the short term treatment of primary insomnia characterised by poor quality of sleep in patients who are aged 55 or over.Other - Research that is not of generic health relevance and not applicable to specific health categories listed above
ACTRN12615000143527Zenith Technology Corp Ltd28
已完成
1 期
Comparative assessment of the absorption of a generic formulation of quetiapine prolonged release tablet against the innovator quetiapine tablet conducted under fasting conditions and at steady state in healthy male and female volunteersBioequivalence study conducted in healthy volunteers comparing two formulations of quetiapine with no health condition or problem studied. Although this study is being conducted in healthy volunteers who are not being treated for the condition to which the medicine is used, quetiapine belongs to a class of medicines called an atypical antipsychotic drug and is prescribed for the maintenance treatment of Bipolar and schizophrenia.Bioequivalence study conducted in healthy volunteers comparing two formulations of quetiapine with no health condition or problem studied.Although this study is being conducted in healthy volunteers who are not being treated for the condition to which the medicine is used, quetiapine belongs to a class of medicines called an atypical antipsychotic drug and is prescribed for the maintenance treatment of Bipolar and schizophrenia.Other - Research that is not of generic health relevance and not applicable to specific health categories listed above
ACTRN12613001134718Zenith Technology Corporation Limited36
已完成
1 期
Comparative assessment of the absorption of a generic formulation of ibuprofen sustained release tablet against the innovator ibuprofen tablet conducted under fasting conditions and at steady state in healthy male and female volunteers
ACTRN12615000078550Zenith Technology Corporation Limited24
已完成
1 期
Comparative assessment of the absorption of a generic formulation of desvenlafaxine extended release tablet against the innovator desvenlafaxine extended release tablet conducted under fasting conditions and at steady state in healthy male and female volunteersBioequivalence study conducted in healthy volunteers comparing two formulations of desvenlafaxine with no health condition or problem studied. Although this study is being conducted in healthy volunteers who are not being treated for the condition to which the medicine is used, desvenlafaxine belongs to a class of medicines called Serotonin-Nonadrenaline Reuptake Inhibitors and is an antidepressant prescribed for the treatment and prevention of relapse of depression.Bioequivalence study conducted in healthy volunteers comparing two formulations of desvenlafaxine with no health condition or problem studied.Although this study is being conducted in healthy volunteers who are not being treated for the condition to which the medicine is used, desvenlafaxine belongs to a class of medicines called Serotonin-Nonadrenaline Reuptake Inhibitors and is an antidepressant prescribed for the treatment and prevention of relapse of depression.Other - Research that is not of generic health relevance and not applicable to specific health categories listed above
ACTRN12613000630718Zenith Technology Corporation Limited26
已完成
1 期
Comparative assessment of the absorption of a generic formulation of 100 mg desvenlafaxine extended release tablet against the innovator 100 mg desvenlafaxine extended release tablet conducted under fasting conditions and at steady state in healthy male and female volunteers
ACTRN12615000869572Zenith Technology Corp Ltd21
Comparative assessment of the absorption of a... | 临床试验